Which are the best Chinese herbal injections combined with XELOX regimen for gastric cancer?: A PRISMA-compliant network meta-analysis
The optimal Chinese herbal injections (CHIs) combined with XELOX regimen for patients with gastric cancer remains elusive. The aim of our network meta-analysis (NMA) is to explore the best options among different CHIs for gastric cancer. PubMed, Embase, the Cochrane Library, the China National Knowl...
Gespeichert in:
Veröffentlicht in: | Medicine (Baltimore) 2018-03, Vol.97 (12), p.e0127-e0127 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e0127 |
---|---|
container_issue | 12 |
container_start_page | e0127 |
container_title | Medicine (Baltimore) |
container_volume | 97 |
creator | Zhang, Dan Wu, Jiarui Wang, Kaihuan Duan, Xiaojiao Liu, Shi Zhang, Bing |
description | The optimal Chinese herbal injections (CHIs) combined with XELOX regimen for patients with gastric cancer remains elusive. The aim of our network meta-analysis (NMA) is to explore the best options among different CHIs for gastric cancer.
PubMed, Embase, the Cochrane Library, the China National Knowledge Infrastructure Database (CNKI), Wan-fang Database, Cqvip Database (VIP), China Biology Medicine disc (CBMdisc) were searched to identify RCTs which focused on CHIs against gastric cancer. The quality assessment of included randomized controlled trials (RCTs) was conducted by the Cochrane risk of bias tool. Standard pair-wise and Bayesian NMAs were performed to compare the efficacy and safety of different CHIs combined with the XELOX regimen via Stata 13.0 and WinBUGS1.4 software.
A total of 2316 records were searched, the network of evidence included 26 eligible RCTs involving 13 types of CHIs and 2154 patients. The results suggested that Shenqifuzheng+ XELOX, Huachansu+ XELOX, Kangai+ XELOX, Javanica oil emulsion+ XELOX, Aidi injection+ XELOX might be the optimal treatment for gastric cancer in improving the performance status than using XELOX regimen single, with odds ratios (OR) and 95% confidence intervals (CIs) of 2.74 (1.24, 6.17), 8.27 (1.74, 42.43), 4.28 (1.80, 10.48), 5.14 (1.87, 16.28), 0.20 (0.090, 0.44). At the aspects of ADRs (adverse reactions), Compound Kushen+ XELOX, Lentinan+ XELOX, Xiaoaiping injection+ XELOX could obviously relieve leukopenia than only receiving XELOX regimen, and their ORs and 95% CIs were 5.62 (1.41, 36.24), 8.16 (2.25, 29.43), 5.69 (1.85, 15.77). Furthermore, Disodium cantharidinate and vitamin B6+ XELOX, Shenqifuzheng+ XELOX, Kangai+ XELOX, Lentinan+ XELOX could obviously relieve the nausea and vomiting than receiving the XELOX regimen alone, with ORs and 95% CIs of 5.29 (1.30, 23.96), 2.50 (1.16, 5.26), 2.42 (1.06, 5.63), 9.04 (3.24, 26.73). Nevertheless, CHIs combined with XELOX regimen did not confer higher better clinical effectiveness rate over receiving XELOX regimen alone, with nonstatistically significant between-group differences.
As the available evidence suggested that CHIs combined with XELOX regimen could provide treatment benefits for patients with gastric cancer. Among 13 types of CHIs, Javanica oil emulsion and Compound Kushen injection is the optimal treatment in improving the clinical effectiveness rate and performance status, and Lentinan injection was superior in relieving ADRs. |
doi_str_mv | 10.1097/MD.0000000000010127 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5895335</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2016538489</sourcerecordid><originalsourceid>FETCH-LOGICAL-c310t-e5d20dec2ad9505988d49627144e956dbf782373ee5ca1bba58cb3f0c699446a3</originalsourceid><addsrcrecordid>eNpdUVtPFDEUbogGVuQXmJg--jLQ68zUB81mQSTZDUQg8tZ0Omd2ijPt2nYl_AF_t2NAVM7Lefgu5_Ih9IaSQ0pUdbQ6PiR_ixLKqh00o5KXhVSleIFmhDBZVKoSe-hVSrcTiVdM7KI9pmRJBaUz9PNr72yPTQSce8ANpIwXvfOQAPcQGzNg52_BZhd8wjaMzYS1-M7lHt-cLM9vcIS1G8HjLkS8NilHZ7E13kL8-B7P8cWXs8vVvJiUm8EZn7GHfBfiNzxCNoXxZrhPLr1GLzszJDh47Pvo-tPJ1eJzsTw_PVvMl4XllOQCZMtIC5aZVkkiVV23QpWsokLAdFLbdFXNeMUBpDW0aYysbcM7YkulhCgN30cfHnw322aE1oLP0Qx6E91o4r0Oxun_Ee96vQ4_tKyV5FxOBu8eDWL4vp2-pUeXLAyD8RC2STNCS8lrUauJyh-oNoaUInRPYyjRvxPUq2P9PMFJ9fbfDZ80fyLjvwA_kJhZ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2016538489</pqid></control><display><type>article</type><title>Which are the best Chinese herbal injections combined with XELOX regimen for gastric cancer?: A PRISMA-compliant network meta-analysis</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>IngentaConnect Open Access</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><source>Wolters Kluwer Open Access</source><creator>Zhang, Dan ; Wu, Jiarui ; Wang, Kaihuan ; Duan, Xiaojiao ; Liu, Shi ; Zhang, Bing</creator><creatorcontrib>Zhang, Dan ; Wu, Jiarui ; Wang, Kaihuan ; Duan, Xiaojiao ; Liu, Shi ; Zhang, Bing</creatorcontrib><description>The optimal Chinese herbal injections (CHIs) combined with XELOX regimen for patients with gastric cancer remains elusive. The aim of our network meta-analysis (NMA) is to explore the best options among different CHIs for gastric cancer.
PubMed, Embase, the Cochrane Library, the China National Knowledge Infrastructure Database (CNKI), Wan-fang Database, Cqvip Database (VIP), China Biology Medicine disc (CBMdisc) were searched to identify RCTs which focused on CHIs against gastric cancer. The quality assessment of included randomized controlled trials (RCTs) was conducted by the Cochrane risk of bias tool. Standard pair-wise and Bayesian NMAs were performed to compare the efficacy and safety of different CHIs combined with the XELOX regimen via Stata 13.0 and WinBUGS1.4 software.
A total of 2316 records were searched, the network of evidence included 26 eligible RCTs involving 13 types of CHIs and 2154 patients. The results suggested that Shenqifuzheng+ XELOX, Huachansu+ XELOX, Kangai+ XELOX, Javanica oil emulsion+ XELOX, Aidi injection+ XELOX might be the optimal treatment for gastric cancer in improving the performance status than using XELOX regimen single, with odds ratios (OR) and 95% confidence intervals (CIs) of 2.74 (1.24, 6.17), 8.27 (1.74, 42.43), 4.28 (1.80, 10.48), 5.14 (1.87, 16.28), 0.20 (0.090, 0.44). At the aspects of ADRs (adverse reactions), Compound Kushen+ XELOX, Lentinan+ XELOX, Xiaoaiping injection+ XELOX could obviously relieve leukopenia than only receiving XELOX regimen, and their ORs and 95% CIs were 5.62 (1.41, 36.24), 8.16 (2.25, 29.43), 5.69 (1.85, 15.77). Furthermore, Disodium cantharidinate and vitamin B6+ XELOX, Shenqifuzheng+ XELOX, Kangai+ XELOX, Lentinan+ XELOX could obviously relieve the nausea and vomiting than receiving the XELOX regimen alone, with ORs and 95% CIs of 5.29 (1.30, 23.96), 2.50 (1.16, 5.26), 2.42 (1.06, 5.63), 9.04 (3.24, 26.73). Nevertheless, CHIs combined with XELOX regimen did not confer higher better clinical effectiveness rate over receiving XELOX regimen alone, with nonstatistically significant between-group differences.
As the available evidence suggested that CHIs combined with XELOX regimen could provide treatment benefits for patients with gastric cancer. Among 13 types of CHIs, Javanica oil emulsion and Compound Kushen injection is the optimal treatment in improving the clinical effectiveness rate and performance status, and Lentinan injection was superior in relieving ADRs.</description><identifier>ISSN: 0025-7974</identifier><identifier>EISSN: 1536-5964</identifier><identifier>DOI: 10.1097/MD.0000000000010127</identifier><identifier>PMID: 29561411</identifier><language>eng</language><publisher>United States: Wolters Kluwer Health</publisher><subject>Antineoplastic Agents - therapeutic use ; Antineoplastic Combined Chemotherapy Protocols ; Deoxycytidine - analogs & derivatives ; Drugs, Chinese Herbal - therapeutic use ; Fluorouracil - analogs & derivatives ; Humans ; Network Meta-Analysis ; Stomach Neoplasms - drug therapy ; Systematic Review and Meta-Analysis</subject><ispartof>Medicine (Baltimore), 2018-03, Vol.97 (12), p.e0127-e0127</ispartof><rights>Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c310t-e5d20dec2ad9505988d49627144e956dbf782373ee5ca1bba58cb3f0c699446a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895335/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895335/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27903,27904,53770,53772</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29561411$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhang, Dan</creatorcontrib><creatorcontrib>Wu, Jiarui</creatorcontrib><creatorcontrib>Wang, Kaihuan</creatorcontrib><creatorcontrib>Duan, Xiaojiao</creatorcontrib><creatorcontrib>Liu, Shi</creatorcontrib><creatorcontrib>Zhang, Bing</creatorcontrib><title>Which are the best Chinese herbal injections combined with XELOX regimen for gastric cancer?: A PRISMA-compliant network meta-analysis</title><title>Medicine (Baltimore)</title><addtitle>Medicine (Baltimore)</addtitle><description>The optimal Chinese herbal injections (CHIs) combined with XELOX regimen for patients with gastric cancer remains elusive. The aim of our network meta-analysis (NMA) is to explore the best options among different CHIs for gastric cancer.
PubMed, Embase, the Cochrane Library, the China National Knowledge Infrastructure Database (CNKI), Wan-fang Database, Cqvip Database (VIP), China Biology Medicine disc (CBMdisc) were searched to identify RCTs which focused on CHIs against gastric cancer. The quality assessment of included randomized controlled trials (RCTs) was conducted by the Cochrane risk of bias tool. Standard pair-wise and Bayesian NMAs were performed to compare the efficacy and safety of different CHIs combined with the XELOX regimen via Stata 13.0 and WinBUGS1.4 software.
A total of 2316 records were searched, the network of evidence included 26 eligible RCTs involving 13 types of CHIs and 2154 patients. The results suggested that Shenqifuzheng+ XELOX, Huachansu+ XELOX, Kangai+ XELOX, Javanica oil emulsion+ XELOX, Aidi injection+ XELOX might be the optimal treatment for gastric cancer in improving the performance status than using XELOX regimen single, with odds ratios (OR) and 95% confidence intervals (CIs) of 2.74 (1.24, 6.17), 8.27 (1.74, 42.43), 4.28 (1.80, 10.48), 5.14 (1.87, 16.28), 0.20 (0.090, 0.44). At the aspects of ADRs (adverse reactions), Compound Kushen+ XELOX, Lentinan+ XELOX, Xiaoaiping injection+ XELOX could obviously relieve leukopenia than only receiving XELOX regimen, and their ORs and 95% CIs were 5.62 (1.41, 36.24), 8.16 (2.25, 29.43), 5.69 (1.85, 15.77). Furthermore, Disodium cantharidinate and vitamin B6+ XELOX, Shenqifuzheng+ XELOX, Kangai+ XELOX, Lentinan+ XELOX could obviously relieve the nausea and vomiting than receiving the XELOX regimen alone, with ORs and 95% CIs of 5.29 (1.30, 23.96), 2.50 (1.16, 5.26), 2.42 (1.06, 5.63), 9.04 (3.24, 26.73). Nevertheless, CHIs combined with XELOX regimen did not confer higher better clinical effectiveness rate over receiving XELOX regimen alone, with nonstatistically significant between-group differences.
As the available evidence suggested that CHIs combined with XELOX regimen could provide treatment benefits for patients with gastric cancer. Among 13 types of CHIs, Javanica oil emulsion and Compound Kushen injection is the optimal treatment in improving the clinical effectiveness rate and performance status, and Lentinan injection was superior in relieving ADRs.</description><subject>Antineoplastic Agents - therapeutic use</subject><subject>Antineoplastic Combined Chemotherapy Protocols</subject><subject>Deoxycytidine - analogs & derivatives</subject><subject>Drugs, Chinese Herbal - therapeutic use</subject><subject>Fluorouracil - analogs & derivatives</subject><subject>Humans</subject><subject>Network Meta-Analysis</subject><subject>Stomach Neoplasms - drug therapy</subject><subject>Systematic Review and Meta-Analysis</subject><issn>0025-7974</issn><issn>1536-5964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdUVtPFDEUbogGVuQXmJg--jLQ68zUB81mQSTZDUQg8tZ0Omd2ijPt2nYl_AF_t2NAVM7Lefgu5_Ih9IaSQ0pUdbQ6PiR_ixLKqh00o5KXhVSleIFmhDBZVKoSe-hVSrcTiVdM7KI9pmRJBaUz9PNr72yPTQSce8ANpIwXvfOQAPcQGzNg52_BZhd8wjaMzYS1-M7lHt-cLM9vcIS1G8HjLkS8NilHZ7E13kL8-B7P8cWXs8vVvJiUm8EZn7GHfBfiNzxCNoXxZrhPLr1GLzszJDh47Pvo-tPJ1eJzsTw_PVvMl4XllOQCZMtIC5aZVkkiVV23QpWsokLAdFLbdFXNeMUBpDW0aYysbcM7YkulhCgN30cfHnw322aE1oLP0Qx6E91o4r0Oxun_Ee96vQ4_tKyV5FxOBu8eDWL4vp2-pUeXLAyD8RC2STNCS8lrUauJyh-oNoaUInRPYyjRvxPUq2P9PMFJ9fbfDZ80fyLjvwA_kJhZ</recordid><startdate>20180301</startdate><enddate>20180301</enddate><creator>Zhang, Dan</creator><creator>Wu, Jiarui</creator><creator>Wang, Kaihuan</creator><creator>Duan, Xiaojiao</creator><creator>Liu, Shi</creator><creator>Zhang, Bing</creator><general>Wolters Kluwer Health</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20180301</creationdate><title>Which are the best Chinese herbal injections combined with XELOX regimen for gastric cancer?: A PRISMA-compliant network meta-analysis</title><author>Zhang, Dan ; Wu, Jiarui ; Wang, Kaihuan ; Duan, Xiaojiao ; Liu, Shi ; Zhang, Bing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c310t-e5d20dec2ad9505988d49627144e956dbf782373ee5ca1bba58cb3f0c699446a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Antineoplastic Agents - therapeutic use</topic><topic>Antineoplastic Combined Chemotherapy Protocols</topic><topic>Deoxycytidine - analogs & derivatives</topic><topic>Drugs, Chinese Herbal - therapeutic use</topic><topic>Fluorouracil - analogs & derivatives</topic><topic>Humans</topic><topic>Network Meta-Analysis</topic><topic>Stomach Neoplasms - drug therapy</topic><topic>Systematic Review and Meta-Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Dan</creatorcontrib><creatorcontrib>Wu, Jiarui</creatorcontrib><creatorcontrib>Wang, Kaihuan</creatorcontrib><creatorcontrib>Duan, Xiaojiao</creatorcontrib><creatorcontrib>Liu, Shi</creatorcontrib><creatorcontrib>Zhang, Bing</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medicine (Baltimore)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Dan</au><au>Wu, Jiarui</au><au>Wang, Kaihuan</au><au>Duan, Xiaojiao</au><au>Liu, Shi</au><au>Zhang, Bing</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Which are the best Chinese herbal injections combined with XELOX regimen for gastric cancer?: A PRISMA-compliant network meta-analysis</atitle><jtitle>Medicine (Baltimore)</jtitle><addtitle>Medicine (Baltimore)</addtitle><date>2018-03-01</date><risdate>2018</risdate><volume>97</volume><issue>12</issue><spage>e0127</spage><epage>e0127</epage><pages>e0127-e0127</pages><issn>0025-7974</issn><eissn>1536-5964</eissn><abstract>The optimal Chinese herbal injections (CHIs) combined with XELOX regimen for patients with gastric cancer remains elusive. The aim of our network meta-analysis (NMA) is to explore the best options among different CHIs for gastric cancer.
PubMed, Embase, the Cochrane Library, the China National Knowledge Infrastructure Database (CNKI), Wan-fang Database, Cqvip Database (VIP), China Biology Medicine disc (CBMdisc) were searched to identify RCTs which focused on CHIs against gastric cancer. The quality assessment of included randomized controlled trials (RCTs) was conducted by the Cochrane risk of bias tool. Standard pair-wise and Bayesian NMAs were performed to compare the efficacy and safety of different CHIs combined with the XELOX regimen via Stata 13.0 and WinBUGS1.4 software.
A total of 2316 records were searched, the network of evidence included 26 eligible RCTs involving 13 types of CHIs and 2154 patients. The results suggested that Shenqifuzheng+ XELOX, Huachansu+ XELOX, Kangai+ XELOX, Javanica oil emulsion+ XELOX, Aidi injection+ XELOX might be the optimal treatment for gastric cancer in improving the performance status than using XELOX regimen single, with odds ratios (OR) and 95% confidence intervals (CIs) of 2.74 (1.24, 6.17), 8.27 (1.74, 42.43), 4.28 (1.80, 10.48), 5.14 (1.87, 16.28), 0.20 (0.090, 0.44). At the aspects of ADRs (adverse reactions), Compound Kushen+ XELOX, Lentinan+ XELOX, Xiaoaiping injection+ XELOX could obviously relieve leukopenia than only receiving XELOX regimen, and their ORs and 95% CIs were 5.62 (1.41, 36.24), 8.16 (2.25, 29.43), 5.69 (1.85, 15.77). Furthermore, Disodium cantharidinate and vitamin B6+ XELOX, Shenqifuzheng+ XELOX, Kangai+ XELOX, Lentinan+ XELOX could obviously relieve the nausea and vomiting than receiving the XELOX regimen alone, with ORs and 95% CIs of 5.29 (1.30, 23.96), 2.50 (1.16, 5.26), 2.42 (1.06, 5.63), 9.04 (3.24, 26.73). Nevertheless, CHIs combined with XELOX regimen did not confer higher better clinical effectiveness rate over receiving XELOX regimen alone, with nonstatistically significant between-group differences.
As the available evidence suggested that CHIs combined with XELOX regimen could provide treatment benefits for patients with gastric cancer. Among 13 types of CHIs, Javanica oil emulsion and Compound Kushen injection is the optimal treatment in improving the clinical effectiveness rate and performance status, and Lentinan injection was superior in relieving ADRs.</abstract><cop>United States</cop><pub>Wolters Kluwer Health</pub><pmid>29561411</pmid><doi>10.1097/MD.0000000000010127</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0025-7974 |
ispartof | Medicine (Baltimore), 2018-03, Vol.97 (12), p.e0127-e0127 |
issn | 0025-7974 1536-5964 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5895335 |
source | MEDLINE; DOAJ Directory of Open Access Journals; IngentaConnect Open Access; PubMed Central; Alma/SFX Local Collection; EZB Electronic Journals Library; Wolters Kluwer Open Access |
subjects | Antineoplastic Agents - therapeutic use Antineoplastic Combined Chemotherapy Protocols Deoxycytidine - analogs & derivatives Drugs, Chinese Herbal - therapeutic use Fluorouracil - analogs & derivatives Humans Network Meta-Analysis Stomach Neoplasms - drug therapy Systematic Review and Meta-Analysis |
title | Which are the best Chinese herbal injections combined with XELOX regimen for gastric cancer?: A PRISMA-compliant network meta-analysis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T18%3A08%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Which%20are%20the%20best%20Chinese%20herbal%20injections%20combined%20with%20XELOX%20regimen%20for%20gastric%20cancer?:%20A%20PRISMA-compliant%20network%20meta-analysis&rft.jtitle=Medicine%20(Baltimore)&rft.au=Zhang,%20Dan&rft.date=2018-03-01&rft.volume=97&rft.issue=12&rft.spage=e0127&rft.epage=e0127&rft.pages=e0127-e0127&rft.issn=0025-7974&rft.eissn=1536-5964&rft_id=info:doi/10.1097/MD.0000000000010127&rft_dat=%3Cproquest_pubme%3E2016538489%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2016538489&rft_id=info:pmid/29561411&rfr_iscdi=true |